Deepti Tandon
Deepti Tandon has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Adesola Olumide
Institute of Child Health, College of Medicine, University of Ibadan
3 shared publications - Beena Joshi
Department of Operational & Implementation Research, Indian Council of Medical Research-National Institute of Research in Reproductive and Child Health, Mumbai, Maharashtra, India
3 shared publications - Donat Shamba
Ifakara Health Institute, Ifakara, Tanzania
3 shared publications - Ester Elisaria
Ifakara Health Institute
3 shared publications - James Kiarie
Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland
3 shared publications - Komal Preet Allagh
World Health Organization, Geneva, Switzerland
3 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by JMIR Publications Inc. in Interactive Journal of Medical Research
- Vol. 14, e59874
Impact of the COVID-19 Pandemic on Contraceptive Services at Selected Primary Health Care Facilities in India, Nigeria, and Tanzania: Cross-Sectional Study
Background: The COVID-19 pandemic disrupted sexual and reproductive health services, including family planning (FP) and contraceptive services. The World Health Organization conducted a multicountry study in India, Nigeria, and Tanzania to determine the impact of the pandemic on the health system’s readiness to provide contraception services and trends in contraceptive uptake. Objective: This study aimed to determine the status, availability, and health facility readiness to provide contraceptive services and to compare trends in contraceptive uptake before and during the pandemic. Methods: This cross-sectional study was conducted by the Indian Council of Medical Research-National Institute of Research in Reproductive and Child Health (India), the University of Ilorin Teaching Hospital (Nigeria), and the Ifakara Health Institute (Tanzania). A total of 50 primary health facilities (11 in India, 6 in Nigeria, and 33 in Tanzania) were evaluated using a standardized facility assessment questionnaire, completed by the most knowledgeable senior health care provider or administrator at the facility. Monthly data on service utilization and contraceptive availability were collected to capture trends before and during the COVID-19 pandemic. Data were collected from May to August 2022. The study received ethical and scientific approval from the World Health Organization Ethics Review Committee and Research Project Review Panel and national regulatory bodies. Key outcomes included availability of FP guidelines and tools, service disruptions including contraceptive and abortion services, stock-outs, reasons for service disruptions, and mitigation measures to sustain service deliveries. Descriptive analysis was used to summarize the key trends and patterns. Results: Health facilities in all three countries reported shortages of various contraceptives. Contraceptive services were partially disrupted in 91% facilities in India, 83% facilities in Nigeria, and 43% facilities in Tanzania. Abortion services were partially disrupted in all surveyed facilities offering these services in India and Nigeria and in 26.7% of facilities in Tanzania. Client visits declined in health facilities in 2020 compared to 2019 in India (30%) and Nigeria (11%), with a gradual recovery thereafter. In contrast, Tanzania experienced a 1% decline in client visits in 2020. Readiness measures such as telemedicine, task shifting, community outreach, triaging, and patient redirection were implemented to minimize service disruptions. Conclusions: This study provides crucial insights into the challenges posed by the COVID-19 pandemic on contraceptive services and the measures taken to alleviate them. The findings can help countries to better prepare to prevent the disruption of FP and contraceptive services in future pandemics or emergencies.
- 2 December 2025
- Published by JMIR Publications Inc. in Interactive Journal of Medical Research
- Vol. 14, e59874
Open AccessImpact of the COVID-19 Pandemic on Contraceptive Services at Selected Primary Health Care Facilities in India, Nigeria, and Tanzania: Cross-Sectional Study
Background: The COVID-19 pandemic disrupted sexual and reproductive health services, including family planning (FP) and contraceptive services. The World Health Organization conducted a multicountry study in India, Nigeria, and Tanzania to determine the impact of the pandemic on the health system’s readiness to provide contraception services and trends in contraceptive uptake. Objective: This study aimed to determine the status, availability, and health facility readiness to provide contraceptive services and to compare trends in contraceptive uptake before and during the pandemic. Methods: This cross-sectional study was conducted by the Indian Council of Medical Research-National Institute of Research in Reproductive and Child Health (India), the University of Ilorin Teaching Hospital (Nigeria), and the Ifakara Health Institute (Tanzania). A total of 50 primary health facilities (11 in India, 6 in Nigeria, and 33 in Tanzania) were evaluated using a standardized facility assessment questionnaire, completed by the most knowledgeable senior health care provider or administrator at the facility. Monthly data on service utilization and contraceptive availability were collected to capture trends before and during the COVID-19 pandemic. Data were collected from May to August 2022. The study received ethical and scientific approval from the World Health Organization Ethics Review Committee and Research Project Review Panel and national regulatory bodies. Key outcomes included availability of FP guidelines and tools, service disruptions including contraceptive and abortion services, stock-outs, reasons for service disruptions, and mitigation measures to sustain service deliveries. Descriptive analysis was used to summarize the key trends and patterns. Results: Health facilities in all three countries reported shortages of various contraceptives. Contraceptive services were partially disrupted in 91% facilities in India, 83% facilities in Nigeria, and 43% facilities in Tanzania. Abortion services were partially disrupted in all surveyed facilities offering these services in India and Nigeria and in 26.7% of facilities in Tanzania. Client visits declined in health facilities in 2020 compared to 2019 in India (30%) and Nigeria (11%), with a gradual recovery thereafter. In contrast, Tanzania experienced a 1% decline in client visits in 2020. Readiness measures such as telemedicine, task shifting, community outreach, triaging, and patient redirection were implemented to minimize service disruptions. Conclusions: This study provides crucial insights into the challenges posed by the COVID-19 pandemic on contraceptive services and the measures taken to alleviate them. The findings can help countries to better prepare to prevent the disruption of FP and contraceptive services in future pandemics or emergencies.
- 13 June 2025
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 18 (10) , 615-624
Determinants of Cervical Cancer Screening Acceptance among Women in Urban and Tribal Communities of Maharashtra, India: A Cross-sectional Study
Although screening, treatment, and human papillomavirus vaccination can prevent cervical cancer, 17.7% new Indian cases were still recorded in 2022. Illiteracy, undesirable attitudes, and ineffective screening services undermine the effectiveness of cervical cancer screening. We evaluated the knowledge (K), attitude (A), and practices (P) toward cervical cancer and their influence on screening acceptance among urban and tribal women of Maharashtra, India. A cross-sectional study was conducted among 500 urban and 500 tribal women, recruited to equally represent both populations. KAP data on cervical cancer were collected using a structured questionnaire. Participants received free cervical cancer screening. KAP scores were calculated, and their associations with sociodemographic factors and cervical cancer screening were assessed using logistic regression. A total of 939 participants were enrolled. Considering both populations, a total of 530 (56%) participants were unaware about cervical cancer, 296 (72%) about its symptoms, and 250 (61%) of risk factors. Common misconceptions were that only women with symptoms of cervical cancer (166, 18%) or a family history of cervical cancer (385, 41%) needed screening. Fear of pain, bad result, and embarrassment were major perceived barriers. Whereas 65 (6.85%) participants had previously undergone screening, 756 (81%) desired screening and 670 (71.40%) underwent screening. Although women had limited cervical cancer knowledge, their attitude for screening is favorable. Generating awareness and implementing socioculturally acceptable strategies are crucial for amplifying cervical cancer screening among vulnerable women. Prevention Relevance: Despite limited awareness and prevalent misconceptions about cervical cancer screening, the women expressed willingness to undergo screening following appropriate counseling. This highlights the potential for targeted educational interventions to enhance cervical cancer prevention through early detection and improving uptake of screening.
- 13 June 2025
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 18 (10) , 615-624
Determinants of Cervical Cancer Screening Acceptance among Women in Urban and Tribal Communities of Maharashtra, India: A Cross-sectional Study
Although screening, treatment, and human papillomavirus vaccination can prevent cervical cancer, 17.7% new Indian cases were still recorded in 2022. Illiteracy, undesirable attitudes, and ineffective screening services undermine the effectiveness of cervical cancer screening. We evaluated the knowledge (K), attitude (A), and practices (P) toward cervical cancer and their influence on screening acceptance among urban and tribal women of Maharashtra, India. A cross-sectional study was conducted among 500 urban and 500 tribal women, recruited to equally represent both populations. KAP data on cervical cancer were collected using a structured questionnaire. Participants received free cervical cancer screening. KAP scores were calculated, and their associations with sociodemographic factors and cervical cancer screening were assessed using logistic regression. A total of 939 participants were enrolled. Considering both populations, a total of 530 (56%) participants were unaware about cervical cancer, 296 (72%) about its symptoms, and 250 (61%) of risk factors. Common misconceptions were that only women with symptoms of cervical cancer (166, 18%) or a family history of cervical cancer (385, 41%) needed screening. Fear of pain, bad result, and embarrassment were major perceived barriers. Whereas 65 (6.85%) participants had previously undergone screening, 756 (81%) desired screening and 670 (71.40%) underwent screening. Although women had limited cervical cancer knowledge, their attitude for screening is favorable. Generating awareness and implementing socioculturally acceptable strategies are crucial for amplifying cervical cancer screening among vulnerable women. Prevention Relevance: Despite limited awareness and prevalent misconceptions about cervical cancer screening, the women expressed willingness to undergo screening following appropriate counseling. This highlights the potential for targeted educational interventions to enhance cervical cancer prevention through early detection and improving uptake of screening.
- Open Access
- 10 May 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e43329
Determining the Impact of the COVID-19 Pandemic on Availability, Use, and Readiness of Family Planning and Contraceptive Services at Selected Primary Health Care Facilities in Africa and Asia: Protocol for a Mixed Methods Study
Background: The COVID-19 pandemic and the associated social restrictions may have disrupted the provision of essential services, including family planning (FP) and contraceptive services. This protocol is adapted from a generic study protocol titled “Health systems analysis and evaluations of the barriers to availability and readiness of sexual and reproductive health services in COVID-19 affected areas,” conducted by the World Health Organization (WHO) Department of Reproductive Health and Research. Objective: This study aims to assess the availability and use of FP and contraceptive services in primary health facilities during and after the COVID-19 pandemic; assess the risk perceptions of COVID-19 stigma, barriers to access, and quality of services from clients’ and providers’ perspectives in the COVID-19–affected areas; and assess the postpandemic recovery of the facilities in the provision of FP and contraceptive services. Methods: In-depth interviews will be conducted with clients—women in the reproductive age group and their male partners who visit the selected health facilities for FP and contraceptive services—and health providers (the most knowledgeable person on FP and contraceptive service provision) at the selected health facilities. Focus group discussions will be conducted with clients at the selected health facilities and in the community. The in-depth interviews and focus group discussions will help to understand clients’ and health service providers’ perspectives of FP and contraceptive service availability and readiness in COVID-19–affected areas. A cross-sectional health facility assessment will be conducted in all the selected health facilities to determine the health facility infrastructure’s ability and readiness to provide FP and contraceptive services and to capture the trends in FP and contraceptive services available during the COVID-19 pandemic. Scientific approval for this study is obtained from the WHO Research Project Review Panel, and the WHO Ethics Review Committee has given ethical approval in the 3 countries. Results: Using a standardized research protocol will ensure that the results from this study can be compared across regions and countries. The study was funded in March 2021. It received ethics approval from the WHO Ethics Review Committee in February 2022. We completed data collection in September 2022. We plan to complete the data analysis by March 2023. We plan to publish the study results by Summer 2023. Conclusions: The findings from this study will provide a better understanding of the impact of the COVID-19 pandemic on FP and contraceptive services at the facility level, which will help policy makers and health managers develop and strengthen FP policies and services in health facilities to be more responsive to community needs. International Registered Report Identifier (IRRID): DERR1-10.2196/43329
- 10 May 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e43329
Open AccessDetermining the Impact of the COVID-19 Pandemic on Availability, Use, and Readiness of Family Planning and Contraceptive Services at Selected Primary Health Care Facilities in Africa and Asia: Protocol for a Mixed Methods Study
Background: The COVID-19 pandemic and the associated social restrictions may have disrupted the provision of essential services, including family planning (FP) and contraceptive services. This protocol is adapted from a generic study protocol titled “Health systems analysis and evaluations of the barriers to availability and readiness of sexual and reproductive health services in COVID-19 affected areas,” conducted by the World Health Organization (WHO) Department of Reproductive Health and Research. Objective: This study aims to assess the availability and use of FP and contraceptive services in primary health facilities during and after the COVID-19 pandemic; assess the risk perceptions of COVID-19 stigma, barriers to access, and quality of services from clients’ and providers’ perspectives in the COVID-19–affected areas; and assess the postpandemic recovery of the facilities in the provision of FP and contraceptive services. Methods: In-depth interviews will be conducted with clients—women in the reproductive age group and their male partners who visit the selected health facilities for FP and contraceptive services—and health providers (the most knowledgeable person on FP and contraceptive service provision) at the selected health facilities. Focus group discussions will be conducted with clients at the selected health facilities and in the community. The in-depth interviews and focus group discussions will help to understand clients’ and health service providers’ perspectives of FP and contraceptive service availability and readiness in COVID-19–affected areas. A cross-sectional health facility assessment will be conducted in all the selected health facilities to determine the health facility infrastructure’s ability and readiness to provide FP and contraceptive services and to capture the trends in FP and contraceptive services available during the COVID-19 pandemic. Scientific approval for this study is obtained from the WHO Research Project Review Panel, and the WHO Ethics Review Committee has given ethical approval in the 3 countries. Results: Using a standardized research protocol will ensure that the results from this study can be compared across regions and countries. The study was funded in March 2021. It received ethics approval from the WHO Ethics Review Committee in February 2022. We completed data collection in September 2022. We plan to complete the data analysis by March 2023. We plan to publish the study results by Summer 2023. Conclusions: The findings from this study will provide a better understanding of the impact of the COVID-19 pandemic on FP and contraceptive services at the facility level, which will help policy makers and health managers develop and strengthen FP policies and services in health facilities to be more responsive to community needs. International Registered Report Identifier (IRRID): DERR1-10.2196/43329
- Open Access
- 8 October 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Determining the Impact of the COVID-19 Pandemic on Availability, Use, and Readiness of Family Planning and Contraceptive Services at Selected Primary Health Care Facilities in Africa and Asia: Protocol for a Mixed Methods Study (Preprint)
BACKGROUND The COVID-19 pandemic and the associated social restrictions may have disrupted the provision of essential services, including family planning (FP) and contraceptive services. This protocol is adapted from a generic study protocol titled “Health systems analysis and evaluations of the barriers to availability and readiness of sexual and reproductive health services in COVID-19 affected areas,” conducted by the World Health Organization (WHO) Department of Reproductive Health and Research. OBJECTIVE This study aims to assess the availability and use of FP and contraceptive services in primary health facilities during and after the COVID-19 pandemic; assess the risk perceptions of COVID-19 stigma, barriers to access, and quality of services from clients’ and providers’ perspectives in the COVID-19–affected areas; and assess the postpandemic recovery of the facilities in the provision of FP and contraceptive services. METHODS In-depth interviews will be conducted with clients—women in the reproductive age group and their male partners who visit the selected health facilities for FP and contraceptive services—and health providers (the most knowledgeable person on FP and contraceptive service provision) at the selected health facilities. Focus group discussions will be conducted with clients at the selected health facilities and in the community. The in-depth interviews and focus group discussions will help to understand clients’ and health service providers’ perspectives of FP and contraceptive service availability and readiness in COVID-19–affected areas. A cross-sectional health facility assessment will be conducted in all the selected health facilities to determine the health facility infrastructure’s ability and readiness to provide FP and contraceptive services and to capture the trends in FP and contraceptive services available during the COVID-19 pandemic. Scientific approval for this study is obtained from the WHO Research Project Review Panel, and the WHO Ethics Review Committee has given ethical approval in the 3 countries. RESULTS Using a standardized research protocol will ensure that the results from this study can be compared across regions and countries. The study was funded in March 2021. It received ethics approval from the WHO Ethics Review Committee in February 2022. We completed data collection in September 2022. We plan to complete the data analysis by March 2023. We plan to publish the study results by Summer 2023. CONCLUSIONS The findings from this study will provide a better understanding of the impact of the COVID-19 pandemic on FP and contraceptive services at the facility level, which will help policy makers and health managers develop and strengthen FP policies and services in health facilities to be more responsive to community needs. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/43329
- 8 October 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDetermining the Impact of the COVID-19 Pandemic on Availability, Use, and Readiness of Family Planning and Contraceptive Services at Selected Primary Health Care Facilities in Africa and Asia: Protocol for a Mixed Methods Study (Preprint)
BACKGROUND The COVID-19 pandemic and the associated social restrictions may have disrupted the provision of essential services, including family planning (FP) and contraceptive services. This protocol is adapted from a generic study protocol titled “Health systems analysis and evaluations of the barriers to availability and readiness of sexual and reproductive health services in COVID-19 affected areas,” conducted by the World Health Organization (WHO) Department of Reproductive Health and Research. OBJECTIVE This study aims to assess the availability and use of FP and contraceptive services in primary health facilities during and after the COVID-19 pandemic; assess the risk perceptions of COVID-19 stigma, barriers to access, and quality of services from clients’ and providers’ perspectives in the COVID-19–affected areas; and assess the postpandemic recovery of the facilities in the provision of FP and contraceptive services. METHODS In-depth interviews will be conducted with clients—women in the reproductive age group and their male partners who visit the selected health facilities for FP and contraceptive services—and health providers (the most knowledgeable person on FP and contraceptive service provision) at the selected health facilities. Focus group discussions will be conducted with clients at the selected health facilities and in the community. The in-depth interviews and focus group discussions will help to understand clients’ and health service providers’ perspectives of FP and contraceptive service availability and readiness in COVID-19–affected areas. A cross-sectional health facility assessment will be conducted in all the selected health facilities to determine the health facility infrastructure’s ability and readiness to provide FP and contraceptive services and to capture the trends in FP and contraceptive services available during the COVID-19 pandemic. Scientific approval for this study is obtained from the WHO Research Project Review Panel, and the WHO Ethics Review Committee has given ethical approval in the 3 countries. RESULTS Using a standardized research protocol will ensure that the results from this study can be compared across regions and countries. The study was funded in March 2021. It received ethics approval from the WHO Ethics Review Committee in February 2022. We completed data collection in September 2022. We plan to complete the data analysis by March 2023. We plan to publish the study results by Summer 2023. CONCLUSIONS The findings from this study will provide a better understanding of the impact of the COVID-19 pandemic on FP and contraceptive services at the facility level, which will help policy makers and health managers develop and strengthen FP policies and services in health facilities to be more responsive to community needs. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/43329